419 related articles for article (PubMed ID: 27288812)
1. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
Nourbakhsh B; Azevedo C; Maghzi AH; Spain R; Pelletier D; Waubant E
J Neurol Sci; 2016 Jul; 366():229-233. PubMed ID: 27288812
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal associations between brain structural changes and fatigue in early MS.
Nourbakhsh B; Azevedo C; Nunan-Saah J; Maghzi AH; Spain R; Pelletier D; Waubant E
Mult Scler Relat Disord; 2016 Jan; 5():29-33. PubMed ID: 26856940
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.
Maghzi AH; Revirajan N; Julian LJ; Spain R; Mowry EM; Liu S; Jin C; Green AJ; McCulloch CE; Pelletier D; Waubant E
Mult Scler Relat Disord; 2014 Nov; 3(6):720-7. PubMed ID: 25891551
[TBL] [Abstract][Full Text] [Related]
4. Serum neurofilament is associated with progression of brain atrophy and disability in early MS.
Kuhle J; Nourbakhsh B; Grant D; Morant S; Barro C; Yaldizli Ö; Pelletier D; Giovannoni G; Waubant E; Gnanapavan S
Neurology; 2017 Feb; 88(9):826-831. PubMed ID: 28148632
[TBL] [Abstract][Full Text] [Related]
5. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
6. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.
Rudick RA; Fisher E; Lee JC; Duda JT; Simon J
Mult Scler; 2000 Dec; 6(6):365-72. PubMed ID: 11212130
[TBL] [Abstract][Full Text] [Related]
7. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
Kalinin I; Makshakov G; Evdoshenko E
AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Fleischer V; Gonzalez-Escamilla G; Pareto D; Rovira A; Sastre-Garriga J; Sowa P; Høgestøl EA; Harbo HF; Bellenberg B; Lukas C; Ruggieri S; Gasperini C; Uher T; Vaneckova M; Bittner S; Othman AE; Collorone S; Toosy AT; Meuth SG; Zipp F; Barkhof F; Ciccarelli O; Groppa S
Brain; 2024 Jan; 147(1):135-146. PubMed ID: 37642541
[TBL] [Abstract][Full Text] [Related]
10. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.
Rudick RA; Cutter G; Baier M; Fisher E; Dougherty D; Weinstock-Guttman B; Mass MK; Miller D; Simonian NA
Neurology; 2001 May; 56(10):1324-30. PubMed ID: 11376182
[TBL] [Abstract][Full Text] [Related]
11. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
Kim G; Chu R; Yousuf F; Tauhid S; Stazzone L; Houtchens MK; Stankiewicz JM; Severson C; Kimbrough D; Quintana FJ; Chitnis T; Weiner HL; Healy BC; Bakshi R
Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
[TBL] [Abstract][Full Text] [Related]
12. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.
Horakova D; Cox JL; Havrdova E; Hussein S; Dolezal O; Cookfair D; Dwyer MG; Seidl Z; Bergsland N; Vaneckova M; Zivadinov R
J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):407-14. PubMed ID: 17550987
[TBL] [Abstract][Full Text] [Related]
13. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
[TBL] [Abstract][Full Text] [Related]
14. A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
Zivadinov R; Uher T; Hagemeier J; Vaneckova M; Ramasamy DP; Tyblova M; Bergsland N; Seidl Z; Dwyer MG; Krasensky J; Havrdova E; Horakova D
Mult Scler; 2016 Nov; 22(13):1709-1718. PubMed ID: 26883943
[TBL] [Abstract][Full Text] [Related]
15. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
[TBL] [Abstract][Full Text] [Related]
16. The impact of deep grey matter volume on cognition in multiple sclerosis.
Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
[TBL] [Abstract][Full Text] [Related]
17. Atrophy of reward-related striatal structures in fatigued MS patients is independent of physical disability.
Damasceno A; Damasceno BP; Cendes F
Mult Scler; 2016 May; 22(6):822-9. PubMed ID: 26238465
[TBL] [Abstract][Full Text] [Related]
18. The role of global and regional gray matter volume decrease in multiple sclerosis.
Grothe M; Lotze M; Langner S; Dressel A
J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
[TBL] [Abstract][Full Text] [Related]
19. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients.
Fisher E; Rudick RA; Cutter G; Baier M; Miller D; Weinstock-Guttman B; Mass MK; Dougherty DS; Simonian NA
Mult Scler; 2000 Dec; 6(6):373-7. PubMed ID: 11212131
[TBL] [Abstract][Full Text] [Related]
20. Cortical surface thickness, subcortical volumes and disability between races in relapsing-remitting multiple sclerosis.
Bross M; Hackett M; Bernitsas MM; Bao F; Carla-Santiago-Martinez ; Bernitsas E
Mult Scler Relat Disord; 2021 Aug; 53():103025. PubMed ID: 34052742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
